-
公开(公告)号:US20210361867A1
公开(公告)日:2021-11-25
申请号:US17398221
申请日:2021-08-10
Applicant: Abbott Diabetes Care Inc. , Cambridge Enterprise Limited
Inventor: Malgorzata E. Wilinska , Erwin S. Budiman , Gary A. Hayter , Marc B. Taub , Roman Hovorka
IPC: A61M5/172 , A61B5/1495 , A61B5/145 , A61M5/142 , G16H20/17
Abstract: A closed-loop system for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”). The incidence of severe and significant hypoglycemia reduced 2300- and 200-fold, respectively, during simulated overnight closed-loop control with the MPC algorithm using the glucose measurement error model suggesting that the continuous glucose monitoring technologies facilitate safe closed-loop insulin delivery.
-
公开(公告)号:US20210348120A1
公开(公告)日:2021-11-11
申请号:US17277192
申请日:2019-09-23
Inventor: Alfonso Martinez Arias , Matthias Lutolf , Cristina Pina , Giuliana Rossi , Naomi Moris
Abstract: Polarised three-dimensional cellular aggregates (or gastmloids) generated in vitro from one or more pluripotent stem cells are provided. Methods for obtaining polarised three-dimensional cellular aggregates and cells (e.g. progenitor cells and derivatives thereof) obtained from the polarised three-dimensional cellular aggregates are also provided.
-
公开(公告)号:US20210335781A1
公开(公告)日:2021-10-28
申请号:US17350490
申请日:2021-06-17
Applicant: Cambridge Enterprise Limited
Inventor: Martin Arnold , Loizos Efthymiou , Florin Udrea , Giorgia Longobardi , John William Findlay
IPC: H01L27/07 , H01L29/778 , H01L29/20 , H01L27/06 , H01L29/423 , H03K17/0412 , H03K17/0812 , H03K17/30
Abstract: Power semiconductor devices in GaN technology include an integrated auxiliary (double) gate terminal and a pulldown network to achieve a normally-off (E-Mode) GaN transistor with threshold voltage higher than 2V, low gate leakage current and enhanced switching performance. The high threshold voltage GaN transistor has a high-voltage active GaN device and a low-voltage auxiliary GaN device wherein the high-voltage GaN device has the gate connected to the source of the integrated auxiliary low-voltage GaN transistor and the drain being the external high-voltage drain terminal and the source being the external source terminal, while the low-voltage auxiliary GaN transistor has the gate (first auxiliary electrode) connected to the drain (second auxiliary electrode) functioning as an external gate terminal. A pull-down network for the switching-off of the high threshold voltage GaN transistor may be formed by additional auxiliary low-voltage GaN transistors and resistive elements connected with the low-voltage auxiliary GaN transistor.
-
公开(公告)号:US20210265520A1
公开(公告)日:2021-08-26
申请号:US17260912
申请日:2019-07-16
Applicant: Cambridge Enterprise Limited
Inventor: Matthew Applegate , Andrew Irvine , Crispin Barnes
IPC: H01L31/107 , H01L31/0224 , H01L31/0232 , H01L31/18
Abstract: We disclose herein a photodetector comprising at least one absorption region in which photons are absorbed; and a plurality of electrodes disposed on the at least one absorption region, the electrodes being spaced apart from one another. In use, the geometry of at least one electrode is chosen to enhance the formation of an electric field of the requisite magnitude for avalanche multiplication to occur near the at least one electrode.
-
公开(公告)号:US20210133570A1
公开(公告)日:2021-05-06
申请号:US17088771
申请日:2020-11-04
Inventor: Yousun KO , Alex CHADWICK , Robert MULLINS , Daniel BATES
Abstract: A method and apparatus for processing data of a neural network. The method includes: obtaining one or more bit representations of data used for processing a neural network; generating a plurality of candidate profiles based on the bit representations; determining a final profile by comparing compression performances for each of the candidate profiles; and determining an optimal configuration for compressing data of the neural network based on the determined final profile.
-
公开(公告)号:US10942397B2
公开(公告)日:2021-03-09
申请号:US15797795
申请日:2017-10-30
Inventor: Liangjia Zong , Daping Chu , Haining Yang
IPC: G02F1/1337 , G02F1/1362 , H01L21/02 , G02F1/1333 , G02F1/1335 , G02F1/1343
Abstract: A spatial phase modulator and a method for producing a spatial phase modulator are provided. The spatial phase modulator includes a first substrate and a second substrate that are meshed together, and a liquid crystal layer disposed between the two substrates, where a transparent electrode layer and a first alignment and guiding layer are disposed in a cascading manner on a side that is of the first substrate and that faces the liquid crystal layer; and an electrode layer and an insulation medium glass layer are disposed in a cascading manner on a side that is of the second substrate and that faces the liquid crystal layer, where the insulation medium glass layer has an inclined serration structure on a side facing the liquid crystal layer.
-
公开(公告)号:US20210057601A1
公开(公告)日:2021-02-25
申请号:US16964706
申请日:2019-01-25
Applicant: CAMBRIDGE ENTERPRISE LTD
Inventor: Rachel A. OLIVER , Tongtong ZHU , Yingjun LIU , Peter GRIFFIN
Abstract: A method for etching a semiconductor structure (110) is provided, the semiconductor structure comprising a sub-surface quantum structure (30) of a first III-V semiconductor material,beneath a surface layer (31) of a second III-V semiconductor material having a charge carrier density of less than 5×1017 cm3. The sub-surface quantum structure may comprise, for example, a quantum well, or a quantum wire, or a quantum dot. The method comprises the steps of exposing the surface layer to an electrolyte (130), and applying a potential difference between the first III-V semiconductor material and the electrolyte, to electrochemically etch the sub-surface quantum structure (30) to form a plurality of nanostructures, while the surface layer (31) is not etched. A semiconductor structure, uses thereof, and devices incorporating such semiconductor structures are further provided.
-
公开(公告)号:US20210054434A1
公开(公告)日:2021-02-25
申请号:US16317535
申请日:2017-07-13
Applicant: Genome Research Limited , Cambridge Enterprise Limited
Inventor: Velislava Nikolaeva PETROVA , Rachael BASHFORD-ROGERS , Kenneth SMITH , Paul KELLAM
IPC: C12Q1/686 , C12Q1/6869 , G01N33/53 , C07K16/00
Abstract: The invention relates to a kit for amplifying immunoglobulin sequences and methods thereof, and their use and application in methods for the characterisation of a B-cell repertoire.
-
公开(公告)号:US20210052695A1
公开(公告)日:2021-02-25
申请号:US16964695
申请日:2019-01-25
Applicant: Cambridge Enterprise Limited
Inventor: Louise Helen Boyle , Andreas Heinrich Neerincx , Florin Tudor ILCA
IPC: A61K38/16 , C12N5/0783 , C12N5/0784 , C07K14/74
Abstract: This invention relates to peptide-exchange proteins comprising the luminal domain of TAP-binding protein-related (TAPBPR), which functions as a MHC class I peptide-exchange catalyst when presented to mammalian cells either as a soluble extracellular protein or as a membrane bound cell surface protein. This may be useful in modulating immune responses, including for example loading immunogenic peptide onto tumours or other disease cells to induce their recognition by T cells. Peptide-exchange proteins and methods for their use are provided.
-
公开(公告)号:US20210052632A1
公开(公告)日:2021-02-25
申请号:US16959519
申请日:2019-01-16
Applicant: Cambridge Enterprise Limited
Inventor: Melinda DUER , David REID , Uliana BASHTANOVA
IPC: A61K31/7135 , A61K31/28
Abstract: The disclosure provides a selective inhibitor of DNA-binding to poly (ADP-ribose) polymerase 1 (PARP1), or a pharmaceutically acceptable salt or solvate thereof, for use in treating, ameliorating or preventing cancer. The treatment may be given to a subject suffering from or at risk of osteoporosis or a subject requiring a long-term therapy.
-
-
-
-
-
-
-
-
-